Loren Brown > DLA Piper LLP (US) > New York, United States > Lawyer Profile
DLA Piper LLP (US) Offices

1251 6TH AVE,
NEW YORK, NY 10020-1104
NEW YORK
United States
- Firm Profile
- Go to...
Loren Brown

Work Department
Litigation, Arbitration and Investigations; Life Sciences; Healthcare; Regulatory and Government Affairs; Intellectual Property; Employment
Position
Partner; US Vice Chairman, Chair of US Disputes Practice; Member of the Global Board; and Member of the US Executive Committee
Lawyer Rankings
United States > Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
(Leading partners)DLA Piper LLP (US)’s product liability team is a trusted defender of global pharma and medical device companies, having successfully handled numerous high-stakes disputes. It has defended or ended several mass torts through resolution, dispositive preemption, Daubert hearings, and other motions. Leveraging its cross-practice expertise, the team collaborates closely with appellate, regulatory, and life science partners. Atlanta-based Christopher Campbell, co-chair of the product liability group, leads high-profile matters such as Bayer’s global Essure litigation and its phenylephrine cough-cold MDL litigation. Ilana Hope Eisenstein, chair of US litigation based in Philadelphia, specializes in complex issues, developing and managing legal strategy. In New York, Loren Brown chairs the wider US disputes practice and leads the firm’s representation of Novo Nordisk as national trial counsel in litigation related to diabetes and obesity medications Ozempic, Wegovy, and Rybelsu. Boston-based Matthew Holian is another key figure in the practice, frequently serving as national counsel in complex, multi-jurisdictional matters. ‘Client-focused’ Katie Insogna, also in Boston, is ‘outstanding at managing the intricacies of a day-to-day high-stakes mass tort’, while New York’s Lucas Przymusinski leverages his medical background to drive legal strategy. Meanwhile, Steve Huffaker, who joined the Austin office from King & Spalding LLP in September 2024, focuses on mass tort coordination and strategy, early case resolution, group settlements, litigation risk strategy, and fact and expert witness development and discovery.
United States > Dispute resolution > International litigation
DLA Piper LLP (US)‘s team is commended for taking a ‘pragmatic and creative be approach to very difficult and complex projects’. The firm is particularly skilled at handling cross-border enforcement as well as asset recovery. The team notably recently achieved a high value victory for Rusoro Mining Limited linked to the enforcement of a $1.5 billion award against Venezuela. The team also has expertise in the energy sector, acting on complex Energy Charter Treaty enforcement matters. Ilana Hope Eisenstein chairs the practice, based in Philadelphia, while in New York, James Berger and Loren Brown lead the practice. Berger focuses on the enforcement of arbitral awards and foreign judgments, and routinely advises on insurance and asset recovery issues to leading litigation funders and insurers. Also in New York, Charlene Sun and Joseph Wan are noted.
Lawyer Rankings
- Leading partners United States > Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Product liability, mass tort and class action - defense: pharmaceuticals and medical devices United States > Dispute resolution
- International litigation United States > Dispute resolution
Top Tier Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Tax > Financial products
- Tax > International tax
- Real estate > Land use/zoning
- Healthcare > Life sciences
- Healthcare > Life sciences
- Healthcare > Life sciences
- Healthcare > Life sciences
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate
- Government > State attorneys general
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Tax > US taxes: contentious
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: transactional and regulatory
- Insurance > Advice to insurers
- Industry focus > Cannabis
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Finance > Fintech
- Insurance > Insurance: non-contentious
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Media, technology and telecoms > Media and entertainment: transactional
- International trade and national security > National Security
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- M&A/corporate and commercial > Venture capital and emerging companies
- Labor and employment > Workplace and employment counseling
- Media, technology and telecoms > Advertising and marketing: litigation
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Intellectual property > Copyright
- M&A/corporate and commercial > Corporate governance
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Dispute resolution > International litigation
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
- Finance > Capital markets: equity offerings
- International trade and national security > CFIUS
- Finance > Commercial lending > Advice to direct lenders/private credit
- Real estate > Construction (including construction litigation)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy regulation: oil and gas
- Dispute resolution > General commercial disputes
- Government > Government contracts
- Dispute resolution > International arbitration
- Investment fund formation and management > Private equity funds (including venture capital)
- Healthcare > Service providers
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Transport > Rail and road: litigation and regulation